N-(3-Methoxy-4-(oxazol-5-yl)phenyl)-4-methylpentanamide

ID: ALA4875431

PubChem CID: 141435377

Max Phase: Preclinical

Molecular Formula: C16H20N2O3

Molecular Weight: 288.35

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1cc(NC(=O)CCC(C)C)ccc1-c1cnco1

Standard InChI:  InChI=1S/C16H20N2O3/c1-11(2)4-7-16(19)18-12-5-6-13(14(8-12)20-3)15-9-17-10-21-15/h5-6,8-11H,4,7H2,1-3H3,(H,18,19)

Standard InChI Key:  VSLWLKNJZZJPPK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   13.5318   -2.4061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5306   -3.2257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2387   -3.6346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9483   -3.2252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9455   -2.4025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2369   -1.9973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8239   -1.9985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7383   -1.1858    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9389   -1.0161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5304   -1.7239    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0775   -2.3310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8226   -3.6337    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.1152   -3.2246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6567   -3.6327    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3637   -3.2230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0721   -3.6305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3625   -2.4058    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7792   -3.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4875   -3.6282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1946   -3.2185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4888   -4.4454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  2  0
  1  7  1  0
  2 12  1  0
 12 13  1  0
  4 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4875431

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 288.35

Molecular Weight (Monoisotopic): 288.1474

AlogP: 3.72

#Rotatable Bonds: 6

Polar Surface Area: 64.36

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.48

CX Basic pKa: 0.58

CX LogP: 2.44

CX LogD: 2.44

Aromatic Rings: 2

Heavy Atoms: 21

QED Weighted: 0.88

Np Likeness Score: -0.89

References

1. Hartz RA, Ahuja VT, Nara SJ, Kumar CMV, Brown JM, Bristow LJ, Rajamani R, Muckelbauer JK, Camac D, Kiefer SE, Hunihan L, Gulianello M, Lewis M, Easton A, Lippy JS, Surti N, Pattipati SN, Dokania M, Elavazhagan S, Dandapani K, Hamman BD, Allen J, Kostich W, Bronson JJ, Macor JE, Dzierba CD..  (2021)  Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic Pain.,  64  (15.0): [PMID:34270254] [10.1021/acs.jmedchem.1c00472]

Source

Source(1):

• Scientific Literature